Clinical UpdatesDrug News

The price of a life-saving vaccine against five deadly diseases is expected to drop further in 2011, allowing more of… »   

The European Union will ban the use of organic compound Bisphenol A (BPA) in plastic baby bottles from 2011 with… »   

Celldex Therapeutics Inc said its experimental vaccine for the most common type of brain cancer met the main goal of… »   

It’s not often that spontaneous applause erupts halfway through a scientific talk. But when malaria researcher Arjen Dondorp came to… »   

New research being presented at the 2010 FIP Pharmaceutical Sciences World Congress in association with the American Association of Pharmaceutical… »   

A key enzyme in Mycobacterium tuberculosis that enables the microbe to reproduce rapidly could be a golden target for new… »   

Researchers have developed a promising new approach to vaccination for rotavirus, a common cause of severe diarrheal disease that is… »   

As rival drugs fall by the wayside, Novo Nordisk (NOVOb.CO) is confident Victoza, its new diabetes drug, will be a… »   

GlaxoSmithKline Plc’s (GSK.L) top-selling lung drug Advair is set to enjoy a longer lease of life than widely expected,… »   

The pharmaceutical industry’s buying spree will continue and investors may see more big deals as drugmakers seek ways to stave… »   

Nine major pharmaceutical companies have agreed to pool data on drug trials with academic institutions in an effort to improve… »   

David Henry discusses a recent research article in PLoS Medicine that suggests that relationships between doctors and drug companies are… »   

The European Medicines Agency could be leaderless for much of next year, after a series of missteps and a row… »   

FDA’s complete response letter on Qnexa was probably the best Vivus (VVUS) could have hoped for. Given the negative news… »   

Millions of Medicare recipients have been forcibly reassigned to different prescription drug plans because Part D reimbursements to insurance companies… »